| Stockholm | |
| 29 | |
| Develops, manufactures, and commercializes solutions for the repair of local cartilage damage in human joints. | |
| Episurf Medical is endeavouring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. As a pioneer and industry leader in patient-specific technology for the treatment of painful joint injuries, Episurf Medical does something no other implant manufacturer has done. Episurf puts the patient in the centre of the diagnosis and design of implants and surgical instruments. By combining advanced 3D-imaging technology with the latest manufacturing technology, Episurf is able to adapt not only each implant to the patients injury and anatomy, but also the surgical instruments used. In this way, Episurf can ensure that each patient receives treatment that is perfectly suited to the anatomy of each patient and, thus, ensure a faster, more secure, and better patient-specific treatment for a more active and healthy life.Episurf Medical addresses a global market in which one out of ten individuals over 25 years of age experience joint problems. Further, Episurfs core target market is the mid-age patients, for whom the existing treatment options are limited. By the end of 2015, Episurf Medical has expanded its first product portfolio, the knee portfolio, to address a market potential in the Western world of over SEK 30 billion and this is only the beginning of Episurf Medicals journey. Currently, the company has four CE approved products and Episurf is currently focusing on commercialization in selected European markets through the establishment of an own sales force. | |
| RYFORS Pal | |
| www,episurf.com | |
| EPISB:SS |
Fiche créée le 10/04/2016 par 
Guillaume vue 35 fois.